BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Apisarnthanarax S, Barry A, Cao M, Czito B, DeMatteo R, Drinane M, Hallemeier CL, Koay EJ, Lasley F, Meyer J, Owen D, Pursley J, Schaub SK, Smith G, Venepalli NK, Zibari G, Cardenes H. External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 2021:S1879-8500(21)00233-2. [PMID: 34688956 DOI: 10.1016/j.prro.2021.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Hatzidakis A, Müller L, Krokidis M, Kloeckner R. Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations. Cancers (Basel) 2022;14:2469. [PMID: 35626073 DOI: 10.3390/cancers14102469] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bae BK, Park HC, Yu JI, Yoo GS, Sinn DH, Choi MS, Oh JH. Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017. Front Oncol 2022;12:928119. [DOI: 10.3389/fonc.2022.928119] [Reference Citation Analysis]
3 Galun D, Mijac D, Filipovic A, Bogdanovic A, Zivanovic M, Masulovic D. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. JPM 2022;12:149. [DOI: 10.3390/jpm12020149] [Reference Citation Analysis]
4 Nguyen AT, Atkins KM, Kamrava M. In Regard to Apisarnthanarax et al. Pract Radiat Oncol 2022;12:e239. [PMID: 35512991 DOI: 10.1016/j.prro.2021.12.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hallemeier CL, Apisarnthanarax S, Dawson LA. BCLC 2022 update: Important advances, but missing external beam radiotherapy. J Hepatol 2022:S0168-8278(21)02306-0. [PMID: 34990748 DOI: 10.1016/j.jhep.2021.12.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 2022. [PMID: 35417569 DOI: 10.1002/cncr.34223] [Reference Citation Analysis]
7 Shen P, Huang W, Dai Y, Lo C, Yang J, Su Y, Wang Y, Lu C, Lin C. Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy. Biomedicines 2022;10:597. [DOI: 10.3390/biomedicines10030597] [Reference Citation Analysis]
8 Rim CH, Park S, Yoon WS, Shin IS, Park HC. Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses. Int J Radiat Biol 2022;:1-30. [PMID: 35758976 DOI: 10.1080/09553002.2022.2094020] [Reference Citation Analysis]
9 Mo A, Velten C, Jiang JM, Tang J, Ohri N, Kalnicki S, Mirhaji P, Nemoto K, Aasman B, Garg M, Guha C, Brodin NP, Kabarriti R. Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence-Based Decision-Making Tool. JCO Clin Cancer Inform 2022;6:e2200024. [PMID: 35671414 DOI: 10.1200/CCI.22.00024] [Reference Citation Analysis]
10 Lewis S, Dawson L, Barry A, Stanescu T, Mohamad I, Hosni A. Stereotactic body radiation therapy for hepatocellular carcinoma: from infancy to ongoing maturity. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100498] [Reference Citation Analysis]
11 Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, Lurje G, Pelzer U, Pratschke J, Schmelzle M, Schöning W. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel) 2022;14:362. [PMID: 35053523 DOI: 10.3390/cancers14020362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey J, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers 2022;14:1901. [DOI: 10.3390/cancers14081901] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Apisarnthanarax S, Cardenes H. In Reply to Nguyen et al. Pract Radiat Oncol 2022;12:e240. [PMID: 35512992 DOI: 10.1016/j.prro.2022.01.010] [Reference Citation Analysis]